George Mason to commemorate Final Four basketball team, Jim Larranaga’s leadership
Mason is celebrating the 20th anniversary of the Patriots’ Final Four season Dec. 13
Jim Larranaga’s leadership led George Mason to Final Four
Mason is celebrating the 20th anniversary of the Patriots’ Final Four season Dec. 13
Loudoun grand jury indicts 8
A robbery suspect and a man accused of trying to solicit a minor were among eight people indicted Dec. 8 by a Loudoun Circuit Court jury.
Weekend Happenings: Enjoy a concert, find Santa at Gumdrop Square
Celebrate the season with toe-tapping favorites at the AFPO Holiday Pops concert, featuring more than 60 professional musicians. Prefer something with a little more swing? The JazzWorx Big Band Holiday Bash brings roaring horns and sizzling rhythms to keep your…
Rosen Law Firm Encourages Balancer Investors to Inquire About Securities Class Action Investigation – BAL
NEW YORK, Dec. 10, 2025 /PRNewswire/ —
GAUZ Investors Have Opportunity to Lead Gauzy Ltd. Securities Fraud Lawsuit
NEW YORK, Dec. 10, 2025 /PRNewswire/ —
ODE TO NOBLE LABORERS
BEIJING, Dec. 10, 2025 /PRNewswire/ — A report from China Daily: From master craftsmen and veterans mastering smart manufacturing to young pioneers in high-tech sectors, China’s industrial workforce is transforming, capturing a sweeping journey of progress as the All-China Federation…
Noah Holdings Hosts Global Black Diamond Summit, Highlights Vision for AI-Driven Global Wealth Management Future
HONG KONG, Dec. 10, 2025 /PRNewswire/ — Noah Holdings Limited (“Noah” or the “Company”) (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive advisory services on global investment and asset allocation primarily for global…
State deems all Prince William County high schools only 'conditionally accredited'
For the first time, all 13 Prince William County high schools have fallen short of full accreditation from the state as a result of the school division’s failure to comply with a single requirement.
Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025
HONG KONG, Dec. 10, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific antibody) combined with chemotherapy as a…